DE60231868D1
(de)
*
|
2001-04-24 |
2009-05-20 |
Purdue Research Foundation |
Folat-mimetika und deren folatrezeptorbindende konjugate
|
MXPA03011094A
(es)
|
2001-05-31 |
2004-12-06 |
Medarex Inc |
Citotoxinas, profarmacos, ligadores, y estabilizadores utiles para ello.
|
DE60326833D1
(de)
*
|
2002-05-15 |
2009-05-07 |
Endocyte Inc |
Vitamin-mitomycin-konjugate
|
DE10254439A1
(de)
*
|
2002-11-21 |
2004-06-03 |
GESELLSCHAFT FüR BIOTECHNOLOGISCHE FORSCHUNG MBH (GBF) |
Tubulysine, Herstellungsverfahren und Tubulysin-Mittel
|
EP2529758A3
(en)
|
2003-01-27 |
2013-01-02 |
Endocyte, Inc. |
Vitamin receptor binding drug delivery conjugates
|
US7691962B2
(en)
|
2004-05-19 |
2010-04-06 |
Medarex, Inc. |
Chemical linkers and conjugates thereof
|
US8288557B2
(en)
|
2004-07-23 |
2012-10-16 |
Endocyte, Inc. |
Bivalent linkers and conjugates thereof
|
US8044200B2
(en)
*
|
2005-03-16 |
2011-10-25 |
Endocyte, Inc. |
Synthesis and purification of pteroic acid and conjugates thereof
|
US7714016B2
(en)
|
2005-04-08 |
2010-05-11 |
Medarex, Inc. |
Cytotoxic compounds and conjugates with cleavable substrates
|
WO2007022493A2
(en)
*
|
2005-08-19 |
2007-02-22 |
Endocyte, Inc. |
Ligand conjugates of vinca alkaloids, analogs, and derivatives
|
KR101364912B1
(ko)
|
2005-08-19 |
2014-02-21 |
엔도사이트, 인코포레이티드 |
복수-약제 리간드 공액체
|
BRPI0617546A2
(pt)
|
2005-09-26 |
2011-07-26 |
Medarex Inc |
conjugado de fÁrmaco-anticorpo, formulaÇço farmacÊutica, mÉtodo para matar uma cÉlula de tumor, mÉtodo para retardar ou interromper o crescimento de um tumor em um sujeito mamÍfero e composto
|
PL1940789T3
(pl)
|
2005-10-26 |
2012-04-30 |
Squibb & Sons Llc |
Metody i związki do otrzymywania analogów cc-1065
|
CA2627190A1
(en)
|
2005-11-10 |
2007-05-24 |
Medarex, Inc. |
Duocarmycin derivatives as novel cytotoxic compounds and conjugates
|
TWI412367B
(zh)
|
2006-12-28 |
2013-10-21 |
Medarex Llc |
化學鏈接劑與可裂解基質以及其之綴合物
|
US20100104626A1
(en)
*
|
2007-02-16 |
2010-04-29 |
Endocyte, Inc. |
Methods and compositions for treating and diagnosing kidney disease
|
CN101616911A
(zh)
*
|
2007-02-21 |
2009-12-30 |
梅达莱克斯公司 |
具有单个氨基酸的化学连接物及其偶联物
|
WO2008106080A2
(en)
*
|
2007-02-27 |
2008-09-04 |
University Of Pittsburgh - Of The Commonwealth System Of Higher Education |
Synthesis of desacetoxytubulysin h and analogs thereof
|
NZ580132A
(en)
|
2007-03-14 |
2012-11-30 |
Endocyte Inc |
Binding ligand linked drug delivery conjugates of tubulysins to vitamins
|
EP2148886B1
(en)
*
|
2007-05-10 |
2014-02-19 |
R & D Biopharmaceuticals Gmbh |
Tubulysine derivatives
|
AU2008268432B2
(en)
|
2007-06-25 |
2015-01-15 |
Endocyte, Inc. |
Conjugates containing hydrophilic spacer linkers
|
US9877965B2
(en)
|
2007-06-25 |
2018-01-30 |
Endocyte, Inc. |
Vitamin receptor drug delivery conjugates for treating inflammation
|
US8476451B2
(en)
*
|
2007-07-20 |
2013-07-02 |
The Regents Of The University Of California |
Tubulysin D analogues
|
EP2209374B1
(en)
|
2007-10-25 |
2014-12-03 |
Endocyte, Inc. |
Tubulysins and processes for preparing
|
IT1394860B1
(it)
|
2009-07-22 |
2012-07-20 |
Kemotech S R L |
Composti farmaceutici
|
US8394922B2
(en)
|
2009-08-03 |
2013-03-12 |
Medarex, Inc. |
Antiproliferative compounds, conjugates thereof, methods therefor, and uses thereof
|
US9163060B2
(en)
*
|
2009-11-12 |
2015-10-20 |
R&D Biopharmaceuticals Gmbh |
Tubulin inhibitors
|
EP2409983A1
(en)
|
2010-07-19 |
2012-01-25 |
Leibniz-Institut für Pflanzenbiochemie (IPB) |
Tubulysin analogues
|
CN103140227B
(zh)
|
2010-08-06 |
2016-01-20 |
恩多塞特公司 |
制备微管蛋白细胞溶素的方法
|
KR101972303B1
(ko)
|
2011-06-10 |
2019-04-25 |
메르사나 테라퓨틱스, 인코포레이티드 |
단백질-중합체-약물 접합체
|
WO2013126797A1
(en)
|
2012-02-24 |
2013-08-29 |
Purdue Research Foundation |
Cholecystokinin b receptor targeting for imaging and therapy
|
US20140080175A1
(en)
|
2012-03-29 |
2014-03-20 |
Endocyte, Inc. |
Processes for preparing tubulysin derivatives and conjugates thereof
|
JP6239597B2
(ja)
|
2012-05-15 |
2017-11-29 |
ソレント・セラピューティクス・インコーポレイテッドSorrento Therapeutics, Inc. |
薬物コンジュゲート、コンジュゲーション方法およびその使用
|
PL2872157T3
(pl)
|
2012-07-12 |
2020-07-13 |
Hangzhou Dac Biotech Co., Ltd |
Koniugaty wiążących komórkę cząsteczek ze środkami cytotoksycznymi
|
EP2708243A1
(en)
|
2012-09-17 |
2014-03-19 |
OntoChem GmbH |
Receptor ligand linked cytotoxic molecules
|
CA2887727A1
(en)
|
2012-10-16 |
2014-04-24 |
Endocyte, Inc. |
Drug delivery conjugates containing unnatural amino acids and methods for using
|
MX2015006109A
(es)
|
2012-11-15 |
2016-02-05 |
Endocyte Inc |
Conjugados para el tratamiento de enfermedades causadas por celulas que expresan psma.
|
AU2012395148B2
(en)
|
2012-11-24 |
2016-10-27 |
Hangzhou Dac Biotech Co., Ltd. |
Hydrophilic linkers and their uses for conjugation of drugs to cell binding molecules
|
JP6334553B2
(ja)
|
2012-12-10 |
2018-05-30 |
メルサナ セラピューティクス,インコーポレイティド |
タンパク質−高分子−薬剤コンジュゲート
|
US9872918B2
(en)
|
2012-12-12 |
2018-01-23 |
Mersana Therapeutics, Inc. |
Hydroxyl-polymer-drug-protein conjugates
|
MX356698B
(es)
|
2013-02-14 |
2018-06-11 |
Bristol Myers Squibb Co |
Compuestos de tubulisina, metodos para obtenerlos y uso.
|
US20140249315A1
(en)
|
2013-03-01 |
2014-09-04 |
Endocyte, Inc. |
Processes for preparing tubulysins
|
CN103333133B
(zh)
*
|
2013-06-13 |
2016-06-08 |
西北师范大学 |
一种Tubulysin家族化合物关键中间体TUV的合成方法
|
WO2015127685A1
(en)
|
2014-02-28 |
2015-09-03 |
Hangzhou Dac Biotech Co., Ltd |
Charged linkers and their uses for conjugation
|
WO2015157592A1
(en)
|
2014-04-11 |
2015-10-15 |
Medimmune, Llc |
Bispecific her2 antibodies
|
US10077287B2
(en)
|
2014-11-10 |
2018-09-18 |
Bristol-Myers Squibb Company |
Tubulysin analogs and methods of making and use
|
US10808007B2
(en)
*
|
2015-02-25 |
2020-10-20 |
William Marsh Rice University |
Desacetoxytubulysin H and analogs thereof
|
CA2991973C
(en)
|
2015-07-12 |
2021-12-07 |
Suzhou M-Conj Biotech Co., Ltd. |
Bridge linkers for conjugation of a cell-binding molecule
|
US9839687B2
(en)
|
2015-07-15 |
2017-12-12 |
Suzhou M-Conj Biotech Co., Ltd. |
Acetylenedicarboxyl linkers and their uses in specific conjugation of a cell-binding molecule
|
HUE050312T2
(hu)
|
2015-11-10 |
2020-11-30 |
Medimmune Llc |
ASCT2-RE specifikus kötõmolekulák és alkalmazásaik
|
US11793880B2
(en)
|
2015-12-04 |
2023-10-24 |
Seagen Inc. |
Conjugates of quaternized tubulysin compounds
|
AU2016363013B2
(en)
|
2015-12-04 |
2022-03-10 |
Seagen Inc. |
Conjugates of quaternized tubulysin compounds
|
US10106560B2
(en)
|
2016-06-16 |
2018-10-23 |
Bristol-Myers Squibb Company |
Process and intermediates for making tubulysin analogs
|
KR102459469B1
(ko)
|
2016-11-14 |
2022-10-26 |
항저우 디에이씨 바이오테크 씨오, 엘티디 |
결합 링커, 그러한 결합 링커를 함유하는 세포 결합 분자-약물 결합체, 링커를 갖는 그러한 결합체의 제조 및 사용
|
IL272304B1
(en)
|
2017-08-01 |
2024-06-01 |
Medimmune Llc |
Conjugation of antibody with monoclonal BCMA drug
|
US11274124B2
(en)
|
2017-11-29 |
2022-03-15 |
William Marsh Rice University |
Tubulysin analogues as anticancer agents and payloads for antibody-drug conjugates and methods of treatment therewith
|
IL289458A
(en)
|
2019-06-29 |
2022-07-01 |
Hangzhou Dac Biotech Co Ltd |
A cell-binding conjugated derivative of the tubolisin molecule and a method for its production
|
US20220241377A1
(en)
|
2019-07-24 |
2022-08-04 |
Molgenie GmbH |
Receptor-targeting peptide-drug conjugates
|
CA3193594A1
(en)
|
2020-09-11 |
2022-03-17 |
Medimmune Limited |
Therapeutic b7-h4 binding molecules
|
GB202117928D0
(en)
|
2021-12-11 |
2022-01-26 |
Cancer Research Tech Ltd |
Immunotherapy for cancer
|
WO2023169896A1
(en)
|
2022-03-09 |
2023-09-14 |
Astrazeneca Ab |
BINDING MOLECULES AGAINST FRα
|